Tetraneuron
Biotechnology company that develops a gene therapy with a multifactorial approach against Alzheimer's disease and other neurodegenerative diseases
Tetraneuron has raised €9.9M across 2 funding rounds from 1 investor, most recently a round in Jan 2026. Based in Valencia, Spain; active in Healthtech. Data as of 28 Oct 2026.
Valencia, Spaintetraneuron.com/es ↗
Total raised
€9.9M
€9,900,000
Funding rounds
2
Investors
1
distinct backers
Active since
2022-12
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDTetraneuron — funding by year — interactive chart.
Data table
| Tetraneuron — funding by year | |
|---|---|
| 2022 | €5.0M |
| 2026 | €4.9M |
Signals
High confidenceRaise-next likelihood34
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-21 | Other | €4.9M | GIMIC Ventures | View deal → |
| 2022-12-27 | Other | €5.0M | — | View deal → |
Investors
1Related news
- Tetraneuron alcanza los €5 millones en una ronda para su terapia génica contra el alzhéimerwebcapitalriesgo.com · 2022-12
- elreferente.es
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData